Latest Breaking News On - Development of global rare diseases - Page 1 : comparemela.com

The European Commission (EC) has given approval to the first PEGylated enzyme replacement therapy to treat Fabry disease.

Diego ardigDror bashanChiesi groupDevelopment of global rare diseasesEuropean medicines agencyEuropean commissionProtalix biotherapeutics incHead of researchGlobal rare diseasesChief executive